The Tylenol brand is owned by Kenvue, a company that was spun off from Johnson & Johnson in 2023. Kenvue is an independent consumer health company that includes Tylenol among its portfolio of products. The Tylenol brand itself was first introduced in 1955 by McNeil Laboratories, which Johnson & Johnson acquired in 1959. After the spin-off, Kenvue took over Tylenol and other consumer health brands formerly part of Johnson & Johnson's consumer healthcare division.
